Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Tanaka

Showing results (161-170 of 198) with videos related to

Pageof 20
Sort By:
Bioscience of Microbiota, Food and Health|April 2, 2024
Efficacy and safety of rifaximin in patients with chronic intestinal pseudo-obstruction: a randomized, double-blind, placebo-controlled, phase II-a exploratory trialHidenori Ohkubo, Takaomi Kessoku, Kosuke Tanaka, et al.
Frontiers in Medicine|July 24, 2025
Patients with symptomatic uncomplicated diverticular disease have high fecal bile acid concentrationsTsumugi Jono, Yuki Kasai, Takaomi Kessoku, et al.
Diabetes Research and Clinical Practice|August 24, 2020
Associations between glycosylated hemoglobin level at less than 24 weeks of gestation and adverse pregnancy outcomes in Japan: The Japan Environment and Children's Study (JECS)Noriyuki Iwama, Takashi Sugiyama, Hirohito Metoki, et al.
Cancer Research|July 11, 2021
Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung CancerYukie Kashima, Daisuke Shibahara, Ayako Suzuki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 18, 2013
Cytokeratin 19 fragment predicts the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor in non-small-cell lung cancer harboring EGFR mutationKosuke Tanaka, Akito Hata, Reiko Kaji, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|October 20, 2022
Comparison of long-term prognosis between non-obese and obese patients with non-alcoholic fatty liver diseaseMichihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2017
Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003)Akito Hata, Nobuyuki Katakami, Yoshihiro Hattori, et al.
Frontiers in Nutrition|June 29, 2023
Clinical trial of a probiotic and herbal supplement for lung healthNancy M Wenger, Luhua Qiao, Teodora Nicola, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 8, 2018
Association between alcohol consumption during pregnancy and hypertensive disorders of pregnancy in Japan: the Japan Environment and Children's StudyNoriyuki Iwama, Hirohito Metoki, Hidekazu Nishigori, et al.
Nature Communications|November 19, 2023
CDC7 inhibition induces replication stress-mediated aneuploid cells with an inflammatory phenotype sensitizing tumors to immune checkpoint blockadeTomoko Yamamori Morita, Jie Yu, Yukie Kashima, et al.
Pageof 20

Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
Bioscience of Microbiota, Food and Health|April 2, 2024
Efficacy and safety of rifaximin in patients with chronic intestinal pseudo-obstruction: a randomized, double-blind, placebo-controlled, phase II-a exploratory trialHidenori Ohkubo, Takaomi Kessoku, Kosuke Tanaka, et al.
Frontiers in Medicine|July 24, 2025
Patients with symptomatic uncomplicated diverticular disease have high fecal bile acid concentrationsTsumugi Jono, Yuki Kasai, Takaomi Kessoku, et al.
Diabetes Research and Clinical Practice|August 24, 2020
Associations between glycosylated hemoglobin level at less than 24 weeks of gestation and adverse pregnancy outcomes in Japan: The Japan Environment and Children's Study (JECS)Noriyuki Iwama, Takashi Sugiyama, Hirohito Metoki, et al.
Cancer Research|July 11, 2021
Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung CancerYukie Kashima, Daisuke Shibahara, Ayako Suzuki, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 18, 2013
Cytokeratin 19 fragment predicts the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor in non-small-cell lung cancer harboring EGFR mutationKosuke Tanaka, Akito Hata, Reiko Kaji, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|October 20, 2022
Comparison of long-term prognosis between non-obese and obese patients with non-alcoholic fatty liver diseaseMichihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2017
Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003)Akito Hata, Nobuyuki Katakami, Yoshihiro Hattori, et al.
Frontiers in Nutrition|June 29, 2023
Clinical trial of a probiotic and herbal supplement for lung healthNancy M Wenger, Luhua Qiao, Teodora Nicola, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 8, 2018
Association between alcohol consumption during pregnancy and hypertensive disorders of pregnancy in Japan: the Japan Environment and Children's StudyNoriyuki Iwama, Hirohito Metoki, Hidekazu Nishigori, et al.
Nature Communications|November 19, 2023
CDC7 inhibition induces replication stress-mediated aneuploid cells with an inflammatory phenotype sensitizing tumors to immune checkpoint blockadeTomoko Yamamori Morita, Jie Yu, Yukie Kashima, et al.
Pageof 20